when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

ROCHE · news · pharmadog

← back to ROCHE

News mentioning ROCHE

103 stories

Jul 2, 26Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 studyendpoints

Jun 30, 26These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.biopharma dive

Jun 12, 26STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and morestat

Jun 11, 26STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and morestat

Jun 11, 26Exclusive: Genentech closes infectious disease unit in wave of research layoffsendpoints

Jun 10, 26STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and morestat

Jun 9, 26STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis findsstat

Jun 9, 26STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and morestat

Jun 8, 26Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or reststat

Jun 8, 26#ADA26: AstraZeneca's GLP-1 pill cuts weight by 10.5% after six monthsendpoints

Jun 8, 26STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trialsstat

Jun 8, 26Roche stakes $700M on Nurix’s protein-degrading drugbiopharma dive

Jun 8, 26ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionbiopharma dive

Jun 8, 26STAT+: Novo underwhelmed by drug it once fought Pfizer forstat

Jun 8, 26STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and morestat

Jun 8, 26Nurix to work with Roche on BTK degrader in pact worth up to $2.3Bendpoints

Jun 6, 26#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this yearendpoints

Jun 5, 26#ADA26: Roche's incretin shot works in mid-stage trial in type 1 diabetesendpoints

Jun 5, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Jun 5, 26STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and morestat

Jun 3, 26Lilly, Ascidian link up in RNA exon editing pactbiopharma dive

Jun 2, 26#ASCO26: Roche details narrow failure of breast cancer pill trialendpoints

May 29, 26Pfizer, Innovent strike $10B cancer drug dealbiopharma dive

May 18, 26FDA approves AstraZeneca’s new kind of hypertension drugbiopharma dive

May 15, 26Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workersbiopharma dive

May 14, 26BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclextaendpoints

May 12, 26STAT+: Hims’ sales miss as telehealth competition growsstat

May 8, 26Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive

May 8, 26Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Canceronclive

May 8, 26Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islandsstat

← prevpage 3 of 4next →